Based on transcriptomic mapping from the Human Protein Atlas (Brain Atlas), GLP-1R mRNA is detected across multiple brain regions including the cerebral cortex, hippocampal formation, amygdala, basal ganglia, thalamus, cerebellum, and white matter at normalized transcripts per million (nTPM) 1.0
Diuretics increase urine output, which should theoretically reduce UTI risk by flushing bacteria
Compounded GLP-1 medications are not a substitute for prescribed medical treatment for any condition
Preclinical evidence and translational perspectives Preclinical studies have provided consistent evidence that incretinbased therapies can modulate key mechanisms implicated in neurodegenerative processes, including neuroinflammation, mitochondrial dysfunction, and synaptic resilience